 Burkitt Lymphoma
"Burkitt Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
| Descriptor ID |
D002051
|
| MeSH Number(s) |
C02.256.466.313.165 C02.928.313.165 C04.557.386.480.100 C04.557.386.480.150.165 C04.619.935.313.165 C04.925.313.165 C15.604.515.569.480.100 C15.604.515.569.480.150.165 C20.683.515.761.480.100 C20.683.515.761.480.150.165
|
| Concept/Terms |
Burkitt Lymphoma- Burkitt Lymphoma
- Lymphoma, Burkitt
- Burkitt's Tumor
- Burkitts Tumor
- Tumor, Burkitt's
- Burkitt Tumor
- Tumor, Burkitt
- Burkitt Cell Leukemia
- Cell Leukemia, Burkitt
- Leukemia, Burkitt Cell
- Burkitt Leukemia
- Leukemia, Burkitt
- Leukemia, Lymphoblastic, Burkitt-Type
- Leukemia, Lymphocytic, L3
- Lymphocytic Leukemia, L3
- L3 Lymphocytic Leukemia
- L3 Lymphocytic Leukemias
- Leukemia, L3 Lymphocytic
- Leukemias, L3 Lymphocytic
- Lymphocytic Leukemias, L3
- Burkitt's Lymphoma
- Burkitts Lymphoma
- Lymphoma, Burkitt's
- Burkitt's Leukemia
- Burkitts Leukemia
- Leukemia, Burkitt's
|
Below are MeSH descriptors whose meaning is more general than "Burkitt Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Burkitt Lymphoma".
This graph shows the total number of publications written about "Burkitt Lymphoma" by people in this website by year, and whether "Burkitt Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 | | 1995 | 0 | 2 | 2 | | 1996 | 2 | 0 | 2 | | 2003 | 2 | 0 | 2 | | 2004 | 1 | 0 | 1 | | 2005 | 2 | 0 | 2 | | 2007 | 2 | 1 | 3 | | 2008 | 2 | 0 | 2 | | 2009 | 2 | 0 | 2 | | 2010 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 2 | 0 | 2 | | 2013 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Burkitt Lymphoma" by people in Profiles.
-
Matar CG, Jacobs NT, Speck SH, Lamb TJ, Moormann AM. Does EBV alter the pathogenesis of malaria? Parasite Immunol. 2015 Sep; 37(9):433-45.
-
Rochford R, Moormann AM. Burkitt's Lymphoma. Curr Top Microbiol Immunol. 2015; 390(Pt 1):267-85.
-
Oduor CI, Chelimo K, Ouma C, Mulama DH, Foley J, Vulule J, Bailey JA, Moormann AM. Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma. Am J Trop Med Hyg. 2014 Sep; 91(3):649-54.
-
Torgbor C, Awuah P, Deitsch K, Kalantari P, Duca KA, Thorley-Lawson DA. A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis. PLoS Pathog. 2014 May; 10(5):e1004170.
-
Mulama DH, Bailey JA, Foley J, Chelimo K, Ouma C, Jura WG, Otieno J, Vulule J, Moormann AM. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer. 2014 Feb 1; 134(3):645-53.
-
Willson TD, Podbielski FJ, Lutfi R. An unusual cause of high-grade obstruction in an HIV-positive patient. Am Surg. 2013 Feb; 79(2):E71-2.
-
Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 4; 490(7418):116-20.
-
Snider CJ, Cole SR, Chelimo K, Sumba PO, Macdonald PD, John CC, Meshnick SR, Moormann AM. Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens. PLoS One. 2012; 7(3):e31753.
-
Piriou E, Asito AS, Sumba PO, Fiore N, Middeldorp JM, Moormann AM, Ploutz-Snyder R, Rochford R. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis. 2012 Mar 15; 205(6):906-13.
-
Moormann AM, Snider CJ, Chelimo K. The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis. 2011 Oct; 24(5):435-41.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|